The predatory system that is Cartel Medicine needs “markets.”
The bigger the market, the better.
It needs tools to create those markets.
One of the most fundamental tools is “numbers.”
If you can mind control the population to believe in numbers, and you control those numbers, then you can create ever expanding markets, at will, by changing the numbers.
They have been playing this game with cholesterol and statins for decades.
Turns out they’ve also been playing it with blood pressure.
With thanks to the magnificent work of A Midwestern Doctor (AMD).
Let’s start with another analogy.
Analogy
Imagine you're driving a car, and your blood pressure is like the speed of the car. For years, experts have been lowering the "speed limit" for what's considered safe driving. At first, they said 70 mph was fine, then 65, then 60, and now they're saying anything over 50 is speeding.
This change means a lot more drivers are now considered to be "speeding" even though they haven't changed how they drive. As a result, more people are getting "speeding tickets" (blood pressure medications) and having to pay fines (deal with side effects and costs).
The problem is, just like how a safe driving speed can depend on the road conditions, time of day, and the driver's experience, a healthy blood pressure can vary based on a person's age, overall health, and other factors. Some people might need to drive a bit faster to get where they need to go safely (like how some people might need slightly higher blood pressure for proper blood flow to their organs).
Now, imagine if instead of just handing out more speeding tickets, we focused on making the roads safer, improving car designs, and teaching better driving skills. Similarly, in healthcare, we would achieve better results by addressing the underlying causes of high blood pressure, like stress, diet, and overall cardiovascular health, rather than just trying to lower everyone's "speed" to meet an arbitrary limit.
This approach would lead to healthier outcomes and save money in the long run, just like how better roads and driver education would reduce accidents more effectively than simply lowering speed limits and increasing traffic fines.
25 Questions & Answers
Question 1: What are the main criticisms of the current approach to hypertension treatment?
The current approach to hypertension treatment is criticized for several reasons. Firstly, it's argued that the focus on blood pressure as a primary indicator of cardiovascular health is misguided. AMD suggests that elevated blood pressure could be a symptom of underlying circulatory issues rather than a cause of cardiovascular disease. Additionally, the aggressive lowering of blood pressure, especially in older patients, may lead to adverse effects such as falls, cognitive decline, and organ damage due to insufficient blood flow.
Another major criticism is the continual lowering of blood pressure thresholds for diagnosis and treatment, which has resulted in a large portion of the population being classified as hypertensive. This trend is viewed as potentially driven by pharmaceutical interests rather than clear evidence of improved health outcomes. The efficacy and safety of blood pressure medications, especially when used long-term or in combination, are also questioned.
Question 2: How does conventional wisdom about blood pressure and cardiovascular disease get challenged?
Conventional wisdom about blood pressure and cardiovascular disease is challenged on several fronts. AMD argues that the commonly accepted linear relationship between blood pressure and cardiovascular risk is inaccurate. Instead, it suggests that there is a threshold effect, where risk only significantly increases beyond a certain blood pressure level, which varies with age and individual factors.
Furthermore, the direction of causality is questioned. While it's typically assumed that high blood pressure causes arterial damage and cardiovascular disease, AMD proposes that arterial damage or dysfunction might actually be causing the elevated blood pressure. This perspective shifts the focus from simply lowering blood pressure to addressing the underlying causes of arterial damage and poor circulation.
Question 3: What is zeta potential and how does it relate to hypertension?
Zeta potential refers to the electrical charge difference between colloidal particles and their surroundings in a fluid. In the context of blood, a sufficiently negative zeta potential helps keep blood cells from clumping together. When zeta potential decreases, blood cells may start to aggregate, forming what's referred to as "blood sludge."
This concept relates to hypertension in several ways. Blood sludging can increase resistance in blood vessels, potentially raising blood pressure. It may also trigger compensatory mechanisms where the body increases blood pressure to push these aggregates through smaller vessels. Additionally, blood sludging can affect the small blood vessels that supply larger arteries (vasa vasorum), potentially damaging arterial walls and contributing to atherosclerosis. Improving zeta potential through various means is proposed as a potential way to address hypertension and improve overall cardiovascular health.
Top 10 Takeaways:
90-95% of hypertension cases are classified as "essential hypertension," meaning there's no known cause.
Up to 25% of hypertension diagnoses may be due to inaccurate measurements.
The 2017 guideline change increased the proportion of U.S. adults with hypertension from 32% to 46%.
For adults over 75, 79% of men and 85% of women are now classified as hypertensive under current guidelines.
A re-analysis of the Framingham study data suggests a threshold effect for blood pressure risk, not a linear relationship.1
Aggressively lowering blood pressure in older adults can increase fall risk, with one study showing a 40% higher risk of serious injury from falls in those on moderate-intensity treatment.
Different blood pressure medications can have vastly different effects on cardiovascular outcomes despite similar effects on blood pressure numbers.
A survey in Sweden found that about 1 in 5 blood pressure medication users experience side effects.
Drastic salt reduction typically results in less than a 1% reduction in blood pressure.
Alternative treatments like addressing zeta potential, nutritional deficiencies, and stress reduction can be effective in managing hypertension without medications in many cases.
Question 4: What problems can arise from inaccurate blood pressure measurements?
Inaccurate blood pressure measurements can lead to several significant problems. One major issue is misdiagnosis of hypertension. AMD outlines that as many as 25% of hypertension diagnoses may be due to inaccurate measurements. This can result in unnecessary treatment, exposing patients to potential side effects of medications they don't actually need.
Variability in blood pressure readings, which can be influenced by factors such as stress ("white coat hypertension"), time of day, or recent activities, can also lead to inconsistent diagnoses. Additionally, technical factors like using the wrong cuff size or not accounting for differences between arms can skew readings. These inaccuracies can lead to either overtreatment or undertreatment of blood pressure issues, potentially putting patients at risk of medication side effects or unaddressed cardiovascular problems.
Question 5: Why is the Framingham study's conclusion about blood pressure controversial?
The Framingham study's conclusion about blood pressure is controversial because it established a linear relationship between blood pressure and cardiovascular risk, suggesting that lower blood pressure is always better. This interpretation has been challenged by subsequent analyses.
A re-analysis of the Framingham data in 2000 suggested a different relationship: rather than a linear correlation, there appeared to be a threshold effect. This means that blood pressure had little impact on mortality until it reached a critical level, after which the risk increased exponentially. This threshold varied with age and gender. The controversy arises because this alternative interpretation suggests that aggressively lowering blood pressure below certain levels may not provide additional benefits and could potentially be harmful, especially in older individuals. Despite this, the linear model has continued to influence treatment guidelines, leading to increasingly lower blood pressure targets over time.
Question 6: How have blood pressure treatment guidelines evolved over time?
Blood pressure treatment guidelines have become increasingly stringent over the years. In the 1970s, a systolic blood pressure of 160 mmHg was considered the threshold for treatment. This threshold has been progressively lowered, with the most recent guidelines in 2017 defining hypertension as a blood pressure of 130/80 mmHg or higher.
This evolution has dramatically increased the number of people classified as hypertensive. For example, the 2017 guideline change resulted in nearly half of U.S. adults (46%) being categorized as having high blood pressure, up from about one-third (32%) under the previous definition. For older adults, the impact is even more significant, with 79% of men and 85% of women over 75 now classified as hypertensive. This trend has led to more people being prescribed blood pressure medications, raising concerns about overtreatment.
What is the fundamental untruth?
The fundamental untruth that has been told to the population regarding blood pressure is that lower blood pressure is always better and that aggressively lowering blood pressure with medications is universally beneficial for cardiovascular health.
In simple terms, we've been led to believe that high blood pressure is like a ticking time bomb in our bodies that needs to be defused at all costs. However, the reality is more complex. Blood pressure, like many aspects of our health, exists on a spectrum where both too high and too low can be problematic. The idea that everyone should strive for the same low blood pressure target ignores individual differences and the potential risks of overtreatment.
Moreover, the focus on blood pressure numbers alone is misleading. The underlying health of our blood vessels and overall cardiovascular system is more important than achieving a specific blood pressure number. In many cases, slightly elevated blood pressure is the body's way of ensuring adequate blood flow, especially as we age and our arteries naturally become less flexible.
This oversimplification has led to overdiagnosis and overtreatment, exposing many people, especially older adults, to unnecessary medications and their side effects without clear evidence of benefit in many cases.
Question 7: What are the potential risks associated with blood pressure medications?
Blood pressure medications can carry several potential risks. Common side effects include dizziness, lightheadedness, and fatigue, which can increase the risk of falls, especially in older adults. Some medications can cause electrolyte imbalances, potentially leading to dangerous conditions like hypokalemia (low potassium) or hyperkalemia (high potassium).
Specific classes of drugs have their own risk profiles. For instance, diuretics can cause dehydration and gout, beta-blockers may lead to sexual dysfunction and mask symptoms of low blood sugar in diabetics, and ACE inhibitors can cause a persistent dry cough. More seriously, these medications can sometimes lead to kidney damage, especially in vulnerable populations. There's also concern that overly aggressive blood pressure lowering can lead to inadequate blood flow to vital organs, potentially causing cognitive decline or worsening kidney function in some patients.
Question 8: What is blood sludging and how might it contribute to hypertension?
Blood sludging refers to the aggregation or clumping together of blood cells, which can occur when the blood's zeta potential (electrical charge that keeps cells separated) decreases. This phenomenon can contribute to hypertension in several ways.
Firstly, blood sludging increases the viscosity of blood, making it more difficult for the heart to pump it through the circulatory system. This increased resistance could lead to higher blood pressure. Secondly, larger aggregates of blood cells may have difficulty passing through smaller blood vessels, potentially leading to micro-obstructions. The body responds by increasing blood pressure to push these aggregates through. Lastly, blood sludging can affect the small blood vessels (vasa vasorum) that supply the walls of larger arteries. If these become obstructed, it could lead to damage of the arterial walls, potentially contributing to atherosclerosis and further increasing blood pressure.
Question 9: How does Chinese medicine view hypertension differently?
Chinese medicine approaches hypertension from a different perspective than Western medicine. In certain schools of Chinese medicine, hypertension is often associated with the concept of "blood stasis," which bears similarities to the Western concept of blood sludging.
One pattern identified in Chinese medicine involves blood stasis leading to fluid leakage from blood vessels and subsequent inflammation. This pattern is often observed in diabetics with high blood sugar. Another pattern involves a strong, full quality in the pulse, believed to be due to the heart or kidneys not receiving enough blood, causing the heart to pump harder. Chinese medicine practitioners often view hypertension as the body's compensatory mechanism to ensure adequate blood flow to vital organs, rather than as a primary problem to be suppressed.
Treatment in Chinese medicine focuses on addressing these underlying patterns, often through herbs, acupuncture, and lifestyle changes, rather than directly suppressing blood pressure. Some practitioners are cautious about using Western hypertensive medicines, believing they may interfere with the body's natural compensatory mechanisms.
What are the benefits to Cartel Medicine from creating this blood pressure paradigm and narrative:
The system benefits from the current blood pressure paradigm in several ways:
Pharmaceutical profits: By lowering the threshold for hypertension diagnosis, more people are classified as hypertensive, leading to increased prescription of blood pressure medications. This directly benefits pharmaceutical companies by expanding their market.
Increased healthcare utilization: More diagnoses lead to more doctor visits, tests, and ongoing monitoring, which generates revenue for healthcare providers and systems.
Research funding: The perception of hypertension as a widespread health crisis attracts significant research funding, benefiting academic institutions and researchers.
Insurance premiums: Health and life insurance companies can justify higher premiums for individuals diagnosed with hypertension.
Medical device sales: Increased focus on blood pressure leads to more sales of home blood pressure monitors and related devices.
Simplified healthcare metrics: Blood pressure provides an easy-to-measure, quantifiable metric for assessing health, which simplifies patient management and healthcare policy decisions.
Liability protection: Aggressive treatment of high blood pressure can be seen as a way for healthcare providers to protect themselves against malpractice claims.
Food industry influence: The focus on salt reduction as a primary method of blood pressure control benefits companies producing low-sodium foods and salt alternatives.
Chronic disease management: Classifying more people with a chronic condition like hypertension creates a large pool of patients requiring ongoing care, supporting the healthcare industry's business model.
Policy influence: The narrative of a hypertension epidemic can be used to influence health policies, potentially benefiting various stakeholders in the healthcare industry.
By diagnosing many people with high blood pressure, the system creates a large patient population that requires ongoing management, medication, and monitoring. This sustained engagement with the healthcare system generates consistent revenue streams for various sectors, from pharmaceutical companies to healthcare providers, while also justifying continued research funding and policy attention. The broad diagnosis also allows for population-wide interventions, which can be more profitable and easier to implement than individualized approaches to health management.
Question 10: What are some root causes of hypertension that are often overlooked?
Several root causes of hypertension are often overlooked in conventional treatment approaches. Poor zeta potential, which can lead to blood sludging, is considered a significant factor. Nutritional deficiencies, particularly of manganese, zinc, and magnesium, can contribute to weakened and inflexible blood vessels.
Structural issues, such as a misplaced kidney compressing a renal artery, can cause hypertension by triggering the body's blood pressure regulation mechanisms. Chronic inflammation, often due to diet or unresolved infections, can damage arterial walls and contribute to hypertension. Anxiety and excessive stress are also considered major contributors, with some practitioners finding that effectively treating anxiety can resolve hypertension in certain cases.
Additionally, lifestyle factors such as poor sleep, lack of sunlight exposure, and insufficient exercise are viewed as important but often neglected contributors to hypertension. Addressing these root causes, rather than simply treating the symptom of high blood pressure, is seen as a more effective long-term approach to managing hypertension.
Question 11: Why might reducing salt intake not be an effective strategy for managing blood pressure?
Reducing salt intake, despite being a common recommendation, may not be an effective strategy for managing blood pressure for several reasons. Studies have shown that even drastic salt reduction typically results in less than a 1% reduction in blood pressure, which is negligible in terms of health outcomes.
Moreover, low sodium levels are strongly correlated with an increased risk of mortality. The recommended salt consumption target has been associated with a 25% increase in the risk of dying. Hospitals routinely administer large amounts of intravenous sodium chloride to patients without causing significant increases in blood pressure, further challenging the salt-hypertension link. Some argue that the focus on sodium ignores the importance of other electrolytes, particularly chloride and potassium, in maintaining healthy blood pressure. AMD says that issues with salt are more related to additives in processed salt, such as aluminum, rather than the sodium content itself.
Question 12: What issues have been identified with clinical trials on blood pressure medications?
Several issues have been identified with clinical trials on blood pressure medications. One major concern is that many trials focus on the drugs' ability to lower blood pressure numbers rather than on meaningful health outcomes like reduced mortality or improved quality of life. This approach may lead to an overemphasis on numerical targets rather than overall patient health.
There's also criticism that industry-sponsored trials are designed to downplay side effects. For instance, the rates of side effects reported in clinical trials are often lower than those observed in real-world patient surveys. Additionally, trials often exclude elderly patients or those with multiple health conditions, limiting their applicability to the general population. Some studies have shown that different blood pressure medications can have vastly different effects on cardiovascular outcomes despite similar effects on blood pressure numbers, suggesting that the focus on blood pressure alone is misguided.
Summary of side effects:
Blood pressure medications can have various side effects, which differ depending on the type of medication. Here's a summary of the main side effects for the most common classes of blood pressure medications:
Diuretics:
Dehydration
Electrolyte imbalances (especially low potassium and sodium)
Increased uric acid levels, potentially leading to gout
Increased blood sugar, potentially worsening diabetes
Frequent urination
Beta-blockers:
Fatigue and weakness
Cold hands and feet
Dizziness or lightheadedness
Sexual dysfunction
Sleep disturbances
Depression
Slowed heart rate
Masking symptoms of low blood sugar in diabetics
Calcium Channel Blockers:
Swelling in ankles and feet (edema)
Dizziness
Constipation
Headaches
Rapid heartbeat
Flushing
ACE Inhibitors:
Persistent dry cough (affecting 3.9% to 35% of users)
Increased risk of kidney problems
Elevated potassium levels (hyperkalemia)
Dizziness
Headaches
Loss of taste
Slightly increased risk of lung cancer (19% increase)
ARBs (Angiotensin Receptor Blockers):
Similar to ACE inhibitors but generally with fewer side effects
Dizziness
Elevated potassium levels
General side effects across multiple classes:
Increased risk of falls, especially in older adults (28% increased risk)
Lightheadedness and fainting
Potential for inadequate blood flow to organs, leading to issues like cognitive decline or worsening kidney function
It's important to note that a Swedish survey found that about 1 in 5 blood pressure medication users experience side effects. Additionally, these medications can interact with other drugs and may need to be adjusted for patients with multiple health conditions.
Question 13: Why might managing blood pressure in elderly patients require a different approach?
Managing blood pressure in elderly patients requires a different approach due to several factors. As people age, their arteries naturally become stiffer and less flexible, which can lead to higher baseline blood pressure. Aggressively lowering this pressure reduces blood flow to vital organs, potentially causing more harm than benefit.
Elderly patients are more susceptible to side effects from blood pressure medications, particularly falls due to dizziness or lightheadedness. These falls can have severe consequences in older individuals. Additionally, cognitive function in the elderly is sensitive to changes in blood flow, and overly aggressive blood pressure lowering has been associated with cognitive decline. Kidney function also tends to decrease with age, making some patients more vulnerable to the kidney-related side effects of certain blood pressure medications. AMD says that a more conservative approach to blood pressure management, with higher acceptable thresholds, may be more appropriate for many elderly patients.
Question 14: How can nutritional deficiencies contribute to high blood pressure?
Nutritional deficiencies can contribute to high blood pressure in several ways. Manganese deficiency, for instance, can lead to weakened and inflexible blood vessels. Zinc deficiency can also affect blood vessel health and elasticity. Both of these minerals play crucial roles in maintaining the structural integrity of blood vessels.
Magnesium deficiency is particularly significant as magnesium helps blood vessels relax. Without sufficient magnesium, arteries may remain constricted, leading to higher blood pressure. Potassium deficiency can also contribute to hypertension, as potassium helps balance the effects of sodium in the body and promotes healthy blood pressure regulation. AMD explains that addressing these nutritional deficiencies, often through targeted supplementation, can be an effective strategy for managing blood pressure in some patients. It's noted that using specific formulations, such as those from Standard Process, can be particularly effective in strengthening blood vessels and potentially reducing blood pressure.
Question 15: What role do anxiety and stress play in hypertension?
Anxiety and stress play significant roles in hypertension, often underappreciated in conventional treatment approaches. Chronic stress and anxiety can lead to persistent activation of the sympathetic nervous system, which increases heart rate and constricts blood vessels, thereby raising blood pressure. This effect is so pronounced that it has led to the recognition of "white coat hypertension," where blood pressure readings are elevated in clinical settings due to the stress of the visit.
AMD outlines that in many cases, effectively treating anxiety can resolve hypertension without the need for blood pressure medications. Stress reduction techniques, such as deep abdominal breathing through the nose, can increase parasympathetic tone and help relax the nervous system, potentially lowering blood pressure. AMD and colleagues emphasize the importance of addressing psychological factors as part of a comprehensive approach to managing hypertension, particularly in cases where anxiety or excessive stress are contributing factors.
Question 16: Why is blood pressure naturally variable and what implications does this have?
Blood pressure is naturally variable due to numerous factors including stress, physical activity, time of day, and even the position of the body. This variability can be quite significant, with pressures at the periphery (where blood pressure is typically measured) varying by around 14 points.
The implications of this variability are substantial. It can lead to misdiagnosis of hypertension, with some estimates suggesting that 15-30% of hypertension diagnoses are due to "White Coat Hypertension" - temporarily elevated blood pressure due to the stress of a medical visit. This variability can result in patients being unnecessarily prescribed blood pressure medications, potentially exposing them to side effects without actual benefit. It also highlights the importance of multiple measurements over time, including home monitoring, to get a more accurate picture of a person's true blood pressure. The natural variability of blood pressure challenges the notion of rigid treatment thresholds and suggests that a more flexible, individualized approach to blood pressure management is more appropriate.
Question 17: What does "essential hypertension" mean and why is it significant?
"Essential hypertension" refers to high blood pressure without a known cause, which accounts for 90-95% of all hypertension cases. The term "essential" is essentially a fancy way of saying "we don't know why it's happening."
This concept is significant because it highlights a major gap in our understanding of hypertension. Despite hypertension being one of the most common chronic diseases, in the vast majority of cases, medicine cannot pinpoint a specific cause. This lack of understanding of the underlying mechanisms raises questions about the appropriateness of current treatment approaches, which often focus on lowering blood pressure numbers rather than addressing root causes. It also suggests that there are multiple factors contributing to high blood pressure that are not being adequately addressed by current diagnostic and treatment paradigms. The prevalence of "essential hypertension" underscores the need for more research into the true causes of high blood pressure and more individualized approaches to treatment.
Question 18: How might atherosclerosis and blood pressure be related?
The relationship between atherosclerosis (the buildup of plaque in arteries) and blood pressure is complex and potentially bidirectional. Conventionally, it's believed that high blood pressure damages arterial walls, leading to atherosclerosis. However, AMD challenges this view, suggesting that atherosclerosis might actually be causing elevated blood pressure.
As arteries become stiffened with plaque, they lose their ability to expand and contract efficiently, potentially leading to increased pressure within them. Additionally, atherosclerotic plaques can narrow arteries, requiring higher pressure to push blood through. AMD also points out that atherosclerosis often affects the small blood vessels (vasa vasorum) that supply the walls of larger arteries. If these become obstructed, it could lead to damage of the arterial walls, potentially triggering mechanisms that raise blood pressure. This perspective suggests that treating the underlying causes of atherosclerosis, rather than just lowering blood pressure, is a more effective approach to overall cardiovascular health.
Question 19: Why is the linear model of blood pressure risk problematic?
The linear model of blood pressure risk, which suggests that lower blood pressure is always better, is problematic for several reasons. Firstly, it doesn't align with biological realities, as it's well-known that blood pressure that's too low can be dangerous. The model implies there's no optimal blood pressure, which contradicts physiological principles.
Secondly, studies have shown that the relationship between blood pressure and mortality is not linear, but rather follows a J-shaped curve. There's a threshold below which lowering blood pressure further doesn't provide benefits and may even increase risk, especially in older adults. This threshold varies with age and individual factors.
The linear model has led to increasingly aggressive blood pressure targets, potentially resulting in overtreatment and unnecessary side effects for many patients. It doesn't account for the risks of overly low blood pressure, such as falls, cognitive decline, or inadequate organ perfusion. By focusing solely on lowering numbers, it diverts attention from addressing underlying cardiovascular health issues. The problematic nature of this model underscores the need for more nuanced, individualized approaches to blood pressure management.
Question 20: How do different types of blood pressure medications affect the body?
Different types of blood pressure medications affect the body in distinct ways:
Diuretics increase urine output, reducing blood volume and thus pressure. They can cause electrolyte imbalances and dehydration.
Beta-blockers slow heart rate and reduce the force of heart contractions. They can cause fatigue, sexual dysfunction, and mask symptoms of low blood sugar in diabetics.
Calcium channel blockers relax blood vessels and reduce heart contraction force. They often cause swelling (edema) and can lead to constipation.
ACE inhibitors block a hormone cascade that raises blood pressure. They commonly cause a dry cough and can potentially harm kidney function.
ARBs work similarly to ACE inhibitors but with a different mechanism and fewer side effects.
Interestingly, these medications often show different degrees of benefit in preventing cardiovascular events, despite similar effects on blood pressure numbers. This suggests that their impacts on health go beyond simply lowering blood pressure and highlights the importance of matching the right medication to each patient's specific situation.
Question 21: Why are side effects from blood pressure medications be underreported?
Side effects from blood pressure medications are underreported for several reasons. Firstly, clinical trials, often sponsored by pharmaceutical companies, are designed in ways that downplay side effects. The controlled environment of trials doesn't always reflect real-world usage, potentially missing long-term or less common side effects.
Secondly, there's often a disconnect between patients' experiences and doctors' perceptions. A 1982 study showed that while 41% of patients felt their quality of life had worsened on blood pressure medications, only 3% of doctors recognized this deterioration. This suggests that doctors may not always be attuned to or inquiring about the full range of side effects patients experience.
Additionally, patients may not report milder side effects, attributing them to age or other factors. The gradual onset of some side effects can make them less noticeable or easily dismissed. Lastly, the focus on numerical blood pressure targets in clinical practice may overshadow discussions about quality of life and side effects. This underreporting can lead to an overly optimistic view of these medications' tolerability and impact on patients' overall well-being.
Question 22: How does blood pressure relate to organ damage?
The relationship between blood pressure and organ damage is complex. Conventionally, it's believed that chronically elevated blood pressure can damage organs over time, particularly the heart, brain, and kidneys. This damage is thought to occur through increased strain on blood vessels and the heart, potentially leading to conditions like heart failure, stroke, and kidney disease.
However, AMD presents a more nuanced view. It suggests that in some cases, elevated blood pressure is a compensatory mechanism to ensure adequate blood flow to organs, rather than the cause of damage. For instance, in cases of arterial stiffening or narrowing, higher pressure is necessary to maintain sufficient blood flow.
AMD also highlights the risks of overly aggressive blood pressure lowering, particularly in older adults. Lowering blood pressure too much can lead to inadequate perfusion of organs, potentially causing cognitive decline, falls, or worsening kidney function. This perspective suggests that some level of elevated blood pressure is protective in certain situations, and that the relationship between blood pressure and organ health is not as straightforward as often presented.
Question 23: What are some alternative treatments for managing high blood pressure?
Several alternative treatments for managing high blood pressure are discussed:
Addressing zeta potential: This can be done through methods like earthing (direct contact with the earth's electrical charge) or specific nutritional approaches.
Nutritional supplementation: Focusing on minerals like manganese, zinc, and magnesium, which play crucial roles in blood vessel health.
Structural adjustments: Some practitioners have found success in normalizing blood pressure by correcting the position of misplaced kidneys that may be compressing renal arteries.
Stress reduction techniques: Including relaxation exercises and addressing underlying anxiety.
Lifestyle modifications: Improving sleep, increasing sun exposure, regular exercise, and dietary changes.
Traditional Chinese Medicine approaches: Including herbal treatments and acupuncture, particularly techniques aimed at releasing blood stasis.
EECP therapy: A method of rhythmically increasing blood return to the heart, which can improve overall cardiovascular function.
EDTA chelation therapy: Used to remove arterial calcifications and improve zeta potential.
Ultraviolet Blood Irradiation: A therapy that has shown promise in improving blood circulation and reducing blood pressure in some studies.
These alternatives often focus on addressing underlying causes of hypertension rather than simply lowering blood pressure numbers.
Question 24: How has the understanding and treatment of hypertension changed over time?
The understanding and treatment of hypertension have undergone significant changes over time. Initially, the focus was primarily on diastolic blood pressure, with the belief that elevated diastolic pressure indicated too much blood in circulation. This view has since shifted to emphasize systolic pressure more.
Treatment thresholds have continuously lowered over the decades. In the 1970s, a systolic pressure of 160 mmHg was considered the treatment threshold. This has progressively decreased, with recent guidelines defining hypertension at 130/80 mmHg. This trend has dramatically increased the number of people classified as hypertensive and eligible for medication.
The understanding of hypertension's causes has also evolved. While initially viewed as a primary condition, there's growing recognition of its complexity and potential secondary nature to other cardiovascular issues. The focus has shifted from viewing elevated blood pressure as inherently harmful to considering it potentially compensatory in some cases.
Treatment approaches have expanded from purely pharmacological interventions to include lifestyle modifications and alternative therapies. There's also increasing awareness of the potential downsides of aggressive blood pressure lowering, particularly in older adults. Overall, the field has moved towards a more nuanced, individualized approach to hypertension management, though this shift is still ongoing.
Question 25: What are the economic implications of changing blood pressure guidelines?
The economic implications of changing blood pressure guidelines are substantial. Lowering the threshold for hypertension diagnosis significantly increases the number of people classified as hypertensive. For instance, the 2017 guideline change in the U.S. increased the proportion of adults with hypertension from about one-third to nearly half.
This increase in diagnosed hypertension leads to more prescriptions for blood pressure medications, benefiting pharmaceutical companies but increasing healthcare costs for patients and insurers. It also results in more doctor visits and tests, further driving up healthcare expenditures.
For individuals, a hypertension diagnosis can impact insurance premiums and potentially affect employment in certain fields. The increased use of medications also brings the economic burden of managing potential side effects.
On a broader scale, these changes influence public health policies and resource allocation. While proponents argue that earlier intervention could reduce long-term complications and associated costs, critics contend that overdiagnosis and overtreatment may lead to unnecessary expenses and potential harm.
The economic impact extends to research funding as well, potentially directing more resources towards hypertension management at the expense of other health priorities. These economic considerations highlight the far-reaching consequences of guideline changes beyond just clinical practice.
I appreciate you being here.
If you've found the content interesting, useful and maybe even helpful, please consider supporting it through a small paid subscription. While everything here is free, your paid subscription is important as it helps in covering some of the operational costs and supports the continuation of this independent research and journalism work. It also helps keep it free for those that cannot afford to pay.
Please make full use of the Free Libraries.
Unbekoming Interview Library: Great interviews across a spectrum of important topics.
Unbekoming Book Summary Library: Concise summaries of important books.
Stories
I'm always in search of good stories, people with valuable expertise and helpful books. Please don't hesitate to get in touch at unbekoming@outlook.com
For COVID vaccine injury
Consider the FLCCC Post-Vaccine Treatment as a resource.
Baseline Human Health
Watch and share this profound 21-minute video to understand and appreciate what health looks like without vaccination.
This means that the original interpretation of the Framingham study data, which suggested a linear relationship between blood pressure and cardiovascular risk (i.e., lower is always better), was challenged by a re-analysis of the same data.
The re-analysis found that instead of a straight-line relationship, there's actually a "threshold effect." Here's what that means:
Linear relationship (original interpretation): This suggested that as blood pressure increases, the risk of cardiovascular problems increases steadily and continuously. Under this model, lowering blood pressure by any amount would always reduce risk.
Threshold effect (re-analysis finding): This suggests that blood pressure has little impact on cardiovascular risk until it reaches a certain level (the threshold). Once blood pressure exceeds this threshold, the risk starts to increase rapidly.
The threshold isn't the same for everyone - it varies based on factors like age and gender. For example, the threshold might be higher for older individuals.
This finding is significant because it suggests that:
Moderately elevated blood pressure might not be as risky as previously thought.
Aggressively lowering blood pressure below the threshold might not provide additional benefits.
Treatment approaches might need to be more individualized, considering a person's specific threshold rather than aiming for a universal low target.
This re-interpretation challenges the basis for continuously lowering blood pressure targets and suggests that the current approach of "lower is always better" might not be accurate or beneficial for everyone.
Had a doc who raised my medication as I got more anxiety from her raising my dose and threatening me with heart damage . Just a feedback loop. I was so stressed she gave me a Rx for anti stress drugs. I didnt take them. I quit seeing her and turned off all sources of stress (mainly the MSM right at lockdown time.) that prevented me from absorbing the massive propaganda campaign of fear. I was then able to get the truth of what was really going on through my alternative health sources. It’s still off and I remain unvaxxed. Maybe this saved my life although I don’t give this crap doctor any credit. I give that all to God.
When they came out with 2nd & 3rd hand smoke to justify why non smokers were getting lung cancer, I knew this was a lie. You never smoked, but your neighbors smoke is coming over the fence, or your child in school is sitting next to another who's father smokes, I was like, "say what??" That was over 30 years ago. My research showed, from the AMA & CDC that there were about 12 cases of actual lung cancer that particular year. Say what!! Showed me that lung cancer was very rare, unless you had black lung from being a miner.
Then came eliminating salt and saturated fats bringing in a deluge of new products pushed in grocery stores. But what really knocked my socks off was cholesterol. Turns out normal cholesterol has alway been considered at the level 250-280, ignoring btw those coastal Mediterranean countries, who had "normal" 600 levels. But that's another story. I mean, really, this was genius what they did. Let's lower the level of normal cholesterol to 200 and snatch every American into that category. Talk about a cash cow.
That slight of hand got everyone to believe Cholesterol causes heart disease, when it's actually that low fat eliminating seed oils (that the Med countries never used) caused. And our store shelves were inundated with every seed oil, low-fat tasteless garbage food imaginable.
I have alway had low BP, 25 years at 70/50, next 25 at 90/70 and now 120/70 so I can see how BP rises with age, lack of exercise, sitting in front of a computer like I'm doing right now. But I have seen the difference come over those who have taken BP meds and it ain't pretty. At the time I attributed these changes as age related until I saw a young person on them. One person who took one pill who, in 15 minutes, blacked out and fell off a bench and crashed onto the floor. That dummy was me. And I never took another BP med and never will again. As big a lie as cholesterol